Principles for Evaluation of One Health Surveillance: The EVA Book PDF
Preview Principles for Evaluation of One Health Surveillance: The EVA Book
Marisa Peyre · François Roger Flavie Goutard Editors Principles for Evaluation of One Health Surveillance: The EVA Book Principles for Evaluation of One Health Surveillance: The EVA Book Marisa Peyre • François Roger Flavie Goutard Editors Principles for Evaluation of One Health Surveillance: The EVA Book Editors Marisa Peyre François Roger CIRAD, Deputy Head UMR ASTRE CIRAD Resident Regional Director for research unit Southeast Asia Campus International de Baillarguet Hanoï, Vietnam Montpellier, France Flavie Goutard CIRAD, UMR ASTRE GREASE network coordinator Hanoï, Vietnam ISBN 978-3-030-82726-7 ISBN 978-3-030-82727-4 (eBook) https://doi.org/10.1007/978-3-030-82727-4 © Springer Nature Switzerland AG 2022 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, expressed or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This Springer imprint is published by the registered company Springer Nature Switzerland AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland Foreword The surveillance of animal diseases has been of major importance to global trading markets and has gained even more importance with regard to public health issues due to incidents such as the SARS episode in 2003 and more recently the threat of influenza and the Covid-19 pandemics. Highly contagious animal diseases such as foot and mouth disease are a significant threat to trade and could lead to export bar- riers and major economic losses if not detected early enough. Moreover, zoonotic diseases (transmitted from animals to humans) account for 60% of human infec- tious diseases, while almost 100% of emerging infectious diseases in humans are of animal origin. This early detection of health events is critical to prevent their intro- duction and spread, and to limit their health and economic consequences especially with zoonotic risks as seen with the Covid-19 pandemic. National animal health surveillance systems are in place to ensure this early detection of the emergence and control of circulating diseases. The OIE defines the surveillance of animal diseases as the systematic ongoing collection, collation and analysis of information related to animal health and the timely dissemination of information so that action can be taken. This definition includes critical elements relating to (i) the sustainability of activities in the long term, (ii) communication to relevant actors and (iii) the possibility of follow-up action. The quality of information generated by those systems provides the basis for global trade agreements and health risk prevention and control. Those systems need to be evaluated to ensure their performance and quality, and the optimal use of resources, especially in settings where resources are limited. The surveillance of animal diseases is underpinned by a complex system essen- tially made possible by people sharing health information and making decisions based on it. In their decision-making on whether to share health information with other actors or not, each actor is influenced by his or her own context and constraints (socio-economic, cultural, religious, political): from the source (farmers) to policy- makers and vice versa; through to the entire chain of intermediary actors that com- prise local Veterinary Services (veterinary paraprofessionals, public or private veterinarians, etc.) and political entities (e.g. village chief). The proper functioning of these networks therefore not only depends on the technical and economic con- straints inherent to the organisation of the network and monitoring protocols (strate- gies), but also to the social issues generated by this network of contacts and information flows. However, until recently these aspects were not considered in the v vi Foreword process due to the lack of tools and methodologies available. This book aims to provide key elements and methodological advances to address this gap. International consensus and social acceptance has been achieved around the need to strengthen health surveillance, especially in regard to the Covid-19 emergence, yet the relevant definition of priorities and the appropriate allocation of resources remain major issues: where, when, how and with what funding? The answers to these questions will vary depending on: • the point of view: the priorities defined for a specific monitoring programme will be different for an individual (e.g. a poultry producer), society or state due to the different nature of the costs and benefits generated • the geographical scale considered (local, national, regional or international) • the time period chosen (short, medium or long term) In many countries, according to the outcomes of the OIE PVS missions1 carried out by OIE experts, the performance of animal health surveillance systems is per- fectible. Nevertheless, conclusions on the epidemiology of diseases and decisions are made based on these findings. Evaluation is an essential step in the decision- making cycle to especially ensure the quality of the evidence used. The evaluation of surveillance can be envisaged in a global or targeted way by distinguishing on the one hand the operation of the network (‘network process’) and on the other its gov- ernance (national monitoring strategy, ‘surveillance policy’). This distinction of scale will appeal to different methodological, socio-economic and institutional issues. The evaluation at the network level will try to answer the problem of social construction and the network’s integration into this construction (what are the social issues related to the operation of the network?), by appealing to socio-economic issues, economic and political policies (is the strategy applicable?). At the level of governance, the issues will relate to the health and socio-economic contexts (is the strategy adapted?) and institutional issues (is the strategy applied?). The transparent and objective interpretation of evaluation results allows for more objective decision-making and resource allocation, as well as a definition of more appropriate surveillance strategies and thus an improvement in the acceptability of the system by different stakeholders (local level: producers and veterinarians; national level: national veterinarians, reference laboratories, decision-makers). These aspects are essential when addressing underreporting issues and improving our understanding of the epidemiological cycles of animal and zoonotic diseases, including novel pathogen emerging risk. The issues of priority, sustainability, social acceptance and communication are at the heart of the concerns of policy-makers when it comes to defining and imple- menting their strategies. Over the past decade, governments have seen their budgets dwindle, highlighting the need to evaluate the efficiency of their surveillance actions and to optimise actions to develop health surveillance at the global level. However, these assessments are not simple to implement, owing to both a lack of the 1 https://www.oie.int/solidarity/pvs-pathway/ Foreword vii necessary data and conflicts of interest with other public actions and private actors of health surveillance. Innovative methods and tools such as the ones presented in this EVA book are needed to overcome these shortcomings and to enable countries to optimise the management of their resources in terms of investment in animal health policy. Monique Éloit Director General, World Organisation for Animal Health (OIE) Paris, France EVA Book Sections Summary and Highlights Needs for Evaluation of Health Surveillance This section provides the baseline elements required to understand what is a health surveillance, how does it work and why it needs to be evaluated. It takes the reader through the definition and theoretical basis of surveillance, surveillance systems, evaluation and evaluation of health surveillance systems. The section also presents the different types of evaluation and how they could be applied to evaluate health surveillance systems. Highlights: • Health surveillance is critical to ensure early detection of emerging diseases. • Timely evaluation is required to design and implement efficient and sustainable surveillance systems. • Decision-makers are looking for scientific based evidence on how to best allo- cate resources for health surveillance—including comparing the cost and bene- fits of disease impact, surveillance and control. • Practical and simple guidance on how to implement health surveillance evalua- tion—including economic evaluation of health surveillance systems—is required to better inform decision-making. Evaluation Frameworks and Tools This section provides an overview on the evaluation guidance available to account for the complexity of the surveillance systems under evaluation both in terms of diversity of objectives and diversity of actors. This section provides a step-by-step guidance on how to perform such evaluation and describe the current tools available to facilitate this process. Such tools could be used by technical advisers of health programme decision-makers to provide scientific based evidence on how to best design or improve health surveillance systems performances and process. Highlights: • Health surveillance systems are complex systems made of a diversity of actors addressing different objectives. ix x EVA Book Sections Summary and Highlights • Each actor of the system has its own needs and constraints which can impact the surveillance process—such aspects must be considered in the evaluation. • Integrated evaluation is required to evaluate technical performances but also pro- cess and economic aspects of the surveillance systems. • Integrated evaluation required interdisciplinary approaches combining epidemi- ology, social and economic sciences. • An evaluation process can be split into three main phases: planning; framing and implementing (including reporting). • The EVA Survtool promotes an integrated evaluation approach and can be used by decision-makers to facilitate the evaluation of health surveillance systems. • The Eva tool includes a step-by-step guide on how to best perform the evaluation and provides a reference online platform for health surveillance evaluation methods. Economic Evaluation This section presents the basic principles behind economic evaluation of surveil- lance—highlighting its challenges linked to the close relationship between surveil- lance and intervention and the need to express benefits and cost in monetary terms for classical economic evaluation. This book presents methods applicable in both developed and developing countries to capture these elements and make meaningful recommendations to improve disease surveillance systems worldwide. The applica- tion of participatory approaches to capture social benefits and costs highlights the complexity of the surveillance process and the impact of social and cultural fac- tors—not yet translated into monetary value—on individual decision-making which can also impact national disease surveillance and control policy if they are not con- sidered in the evaluation and surveillance design processes. Highlights: • Perception of surveillance is affected by the socio-economic context. • Disease impact and therefore surveillance benefits in avoiding those impacts are reduced by alternative options linked to the socio-economic context. • People perception is strongly affected by surveillance consequences (= control actions). • Some perceived costs do not have a market value (e.g. emotional distress, moral link to technical network, fear of conflict). • It is necessary to characterize the contextual factors which affect surveillance function and performances and therefore its economic value. • One Health approach can be taken to account for externality of zoonoses or envi- ronmental issues (e.g. AMR): how to measure the added value. • One Health approach can generate intellectual capita that could better inform control measure and generate a measurable health effect. • Gains in information and knowledge should be measured to assess the added value of One Health. EVA Book Sections Summary and Highlights xi • Experimental economics can be used to describe, conceptualize and quantify non-monetary surveillance benefits. – Stated preference method can be used to assign value to benefits with non- market value and to estimate the willingness of farmers to accept different policy arrangement. • Compensation levels are of secondary importance in the decision to report a health event—outstated by the uncertainty of receiving the compensation and the culling strategy. Qualitative Evaluation Methods As seen with the Covid-19 pandemic crisis, social acceptance, communication but also priority and sustainability are at the heart of concerns for decision-makers when it comes to define health surveillance and control strategies. Qualitative meth- ods sometimes combined with quantitative ones are essential to capture such critical elements. This section presents an overview of existing qualitative methods to eval- uate health surveillance systems including the added value of participatory approaches and the remaining challenges in this area. This section provides also detailed information on practical tools recently developed to assess qualitative attri- butes such as acceptability (AccePT method—Chapter 8) and degree of collabora- tion between partners (ECoSur tool—Chapter 9). Highlights: • Socio-economic and cultural constraints impact the decision of the actors of the surveillance system to postpone or not a case of illness. • The types and responses to these constraints is not depending on the country development level; it depends strongly on the structure of the livestock sector concerned. • The design of more effective and efficient surveillance systems, as well as their evaluation, requires the application of innovative methods and tools accounting for the perceptions, expectations and needs of the different actors. • Participatory approaches are flexible enough to account for such socio-economic and cultural constraints. • Acceptability refers to the willingness of individuals and organizations to partici- pate in surveillance, as well as the extent of involvement of each of these users. • The AccePT method is a standardized method to assess the acceptability of sur- veillance via participation of the network’s actors. • The AccePT method also leads to a better acceptability of the evaluation itself thanks to the direct involvement of the actors in the evaluation process. • Collaboration means interactions between actors operating in different surveil- lance components and that improve the value of the surveillance system. • ECoSur (Evaluation of Collaboration for Surveillance) evaluates the organiza- tion, functioning and functionalities of collaboration taking place in a multisec- toral surveillance system such as One Health surveillance systems.
The list of books you might like
